Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bleeding Symptoms of Carriers of Hemophilia A and B

This study has been completed.
Information provided by (Responsible Party):
Anna Olsson, Sahlgrenska University Hospital, Sweden Identifier:
First received: December 9, 2009
Last updated: October 18, 2016
Last verified: October 2016